纤维肌痛和刺激性肠综合征相互作用:肠道微生物群和肠-大脑轴的可能作用
Cinzia Garofalo1, Costanza Maria Cristiani2, Sara Ilari3
1Department of Experimental and Clinical Medicine, "Magna Græcia" University of Catanzaro, 88100 Catanzaro, Italy.
Biomedicines
|June 28, 2023
概括
纤维肌痛和刺激性肠综合征共享重叠的症状和肠道微生物群的改变. 操纵肠道微生物群可能为慢性疼痛和肠道疾病提供新的治疗策略.
科学领域:
- 胃肠病学和神经病学
- 微生物组研究 微生物组研究
背景情况:
- 纤维肌痛 (FM) 和刺激性肠综合征 (IBS) 是慢性疾病,具有重叠的症状,如疼痛,疲劳和情绪障碍.
- FM和IBS的频繁同时发生表明潜在的共同潜在原因.
- 人们越来越认识到肠-大脑轴是影响这两种疾病的关键途径.
研究的目的:
- 审查FM和IBS之间的症状重叠.
- 检查 FM 和 IBS 患者之间肠道微生物群组成的相似之处.
- 基于IBS治疗,探索潜在的针对FM的微生物群治疗方法.
主要方法:
- 文献综述侧重于调查FM和IBS的研究.
- 在FM和IBS报告的临床症状的比较分析.
- 检查肠道微生物群改变在FM和IBS患者的研究.
- 对针对肠道微生物群的治疗干预措施的审查.
主要成果:
- 在FM和IBS的临床表现中存在显著的重叠.
- 在FM和IBS患者中观察到肠道微生物群组成的变化.
- 肠-大脑轴在两种疾病的病理生理学中起着至关重要的作用.
结论:
- 纤维肌痛和刺激性肠综合征有共同的病理生理路径,特别是涉及肠道微生物群和肠-大脑轴.
- 基于微生物群的疗法在IBS中取得了成功,对管理FM症状有希望.
- 对微生物群调节的进一步研究可能会导致治疗慢性疼痛和相关胃肠道问题的新方法.
相关概念视频
Irritable Bowel Syndrome I: Introduction
325
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
325
Chronic Bowel Disorders: Introduction
490
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
490
Irritable Bowel Syndrome III: Medical and Nursing Management
250
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
250
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
199
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
199
Drugs for Treatment of Diarrhea-Predominant IBS
218
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
218
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
360
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
360


